global biomaterials market - analysis and forecast (2017-2021)

www.bisresearch.com

The global biomaterials market in terms of value is estimated to witness a growth at a CAGR of 16.0% between 2017 and 2021. The increasing demand and the growth rate for biomaterials in the market is attributed to their increasing usage in applications of cardiovascular orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), and tissue engineering, among others, in the biomedical end-use industry.

The rising demand is in line with the unique properties and the biocompatabilty of biomaterials. The properties such as high strength, stiffness, corrosion resistance, fatigue strength, biofunctionality, and bioactivity make the biomaterials a preferred choice in the aforementioned applications. The report is a compilation of various segmentations including market breakdown by biomaterial type, sub-type, end-use applications, and different geographical regions. It also includes sections on competitive insights and market dynamics. Herein, the revenue generated from the biomaterials market is tracked to calculate the market size.

While highlighting the key driving and restraining forces for this market, the report also provides a comprehensive section of the application areas of the biomaterials market. It also examines the role of the leading market players involved in this market. The report addresses the following key questions about the global biomaterials market:

• What is the global biomaterials market size in terms of revenue from 2016-2021?

• Which is the dominant type by revenue in the biomaterials market?

• What is the revenue generated by the different biomaterials by type in the biomaterials market?

• What is the revenue generated by the different applications of the biomaterials market?

• What are the different factors driving the market in the forecast period?

• What are the major factors challenging the growth of global biomaterials market?

• What are opportunities for the global biomaterials market?

• What are the key and future trends for the global biomaterials market?

• What kind of new strategies are being adopted by the existing market players to make a mark in the industry?

• What is the revenue generated by the different geographic regions in the biomaterials market?

• Which region will lead the global biomaterials market by the end of the forecast period?

• Which are the existing key market players that have made a mark in the biomaterials market?

Global Biomaterials Market - Analysis and Forecast: 2017 to 2021

Source: Secondary research, expert interviews, and BIS Research Analysis

www.bisresearch.com

XXXX

XX

2016 2017 2021

Leading Players BASF SE

Corbion N.V.

Invibio Biomaterials Solutions

Evonik Industries

Koninklijke DSM N.V.

Collagen Solutions

Celanese Corp

Biological Bone Substitutes

Zimmer Biomet Holdings Inc.

CAGR(2017-2021)

XX%

Global Biomaterials Market: $Billion


The report has put special emphasis on the market share of the type and applications of the biomaterials, globally. The industry analyses have also been undertaken in order to examine the impact of various factors and understand the overall attractiveness of the industry. The most often used strategy for developing a better hold on to the market has been through agreements, collaborations, contracts, and partnerships, followed by new product launches. The company profile section includes highlights of significant information about the key companies involved, along with their financial summaries and key strategies & developmental activities of recent years.

Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications.

Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The cardiovascular application dominated the biomaterials market on the basis of application with a market share of 34% in 2016. On the basis of geography, North America dominated the biomaterials market with a market share of 42.5%, followed Europe and Asia Pacific. Additionally, APAC has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.

www.bisresearch.com


Competitive Analysis Industry TrendsKey Strategies and

DevelopmentsFACTORS INFLUENCING CURRENT MARKET INFORMATION

Market Share of LeadingPlayers

Compound Annual Growth Rate (CAGR) %R&D Analysis

Geographic Usage Pattern

Macro-Economic Factors

Market Restraints/Challenges

Market Drivers

Market Opportunities

Mergers & Acquisitions

New Product Launches& Developments

Agreements, Collaborations, &

Partnerships

Business Expansions & Others

• Metals• Polymers• Ceramic• Natural• Inorganic glass• Regenerative• Radiopaque• Hybrid biomaterial combinations

By Material Type

• Cardiovascular• Orthopedic• Ophthalmology• Dental• Plastic Surgery• Wound Healing• Tissue Engineering• Neurological/Central nervous System• Other Applications

By End-Use Industry

• North America• Europe• Asia-Pacific• South America• Middle East & Africa

By Region

KEY MARKET SEGMENTATION

TABLE OF CONTENTS

www.bisresearch.com

Executive Summary1 Scope and Research Methodology 1.1 Report Scope 1.2 Global Biomaterials Market Research

Methodology 1.2.1 Assumptions and Limitations 1.2.2 Primary Research 1.2.3 Secondary Research 1.2.4 Data Triangulation 1.2.5 Data Analyzing and Market

Estimation2 Market Dynamics 2.1 Market Drivers 2.1.1 Increasing Funds/ Aids by the

Government For Research Purposes 2.1.2 Increasing Plastic Surgery and

Wound Healing Therapies 2.1.3 Increasing Aging/Geriatric Population 2.1.4 Rise in Prevalence of Cardiovascular

Diseases 2.1.5 Increasing Orthopaedic Disorders 2.1.6 Growing Demand for Implantable

Devices 2.1.7 Increasing Awareness of

Regenerative Medicine 2.2 Market Restraints/Challenges 2.2.1 Biocompatibility Issues and Safety

and Stringent Regulations 2.2.2 Limitations of Biomaterial-Based

Products 2.3 Market Opportunities 2.3.1 Increasing Obesity 2.3.2 Patient Awareness and Improved

Lifestyle in Emerging Economies 2.3.3 Introduction of Biomaterials in

Cancer Research 2.4 Key Trends in the Biomaterials Market3 Competitive Insights 3.1 Competitive Analysis 3.1.1 Biomaterials Market Competitive

Analysis

3.2 Opportunity Matrix Analysis 3.3 Country Share Analysis 3.4 Biomaterials in Research & Development 3.5 R&D Analysis of Key Market Players 3.6 Key Strategies and Developments 3.6.1 Agreements, Collaborations,

Contracts, Joint Venture, & Partnerships

3.6.2 Business Expansions 3.6.3 New Product Launches &

Developments 3.6.4 Mergers & Acquisitions 3.6.5 Others4 Industry Analysis 4.1 Supply Chain Analysis 4.2 Porter’s Five Forces Analysis 4.2.1 Threat of New Entrants 4.2.2 Threat of Substitutes 4.2.3 Bargaining Power of Buyers 4.2.4 Bargaining Power of Suppliers (Low) 4.2.5 Intensity of Competitive Rivalry 4.3 Future Trends and Developments in

Biomaterials Market5 Global Biomaterials Market, by Type 5.1 Metals 5.1.1 Stainless Steel 5.1.2 Titanium and Titanium alloys 5.1.3 Co-Cr Alloys 5.1.4 Magnesium 5.1.5 Gold 5.1.6 Silver 5.1.7 Nitinol 5.1.8 Other Metal Based Biomaterials 5.2 Polymer Based Biomaterials 5.2.1 Polyethylene Terephthalate (PET) 5.2.2 Polypropylene (PP) 5.2.3 Polyetheretherketone (PEEK) 5.2.4 Ultra-High Molecular Weight

Polyethylene (UHMWPE) 5.2.5 Polytetrafluoroethylene (PTFE)


www.bisresearch.com

TABLE OF CONTENTS

5.2.6 Polyglycolide (PGA) 5.2.7 Polyactide (PLA) 5.2.8 Polycaprolactone (PCL) 5.2.9 Polyglycerol Sebacate (PGS) 5.2.10 Polyvinylchloride (PVC) 5.2.11 Silicone Rubber 5.2.12 Nylon 5.2.13 Polymethyl Methacrylate (PMMA) 5.2.14 Other Polymers 5.3 Ceramic Based Biomaterials 5.3.1 Alumina 5.3.2 Calcium Phosphate 5.3.3 Zirconia 5.3.4 Calcium Sulphate 5.3.5 Carbon 5.3.6 Other Ceramic Based Biomaterials 5.4 Natural Based Biomaterials 5.4.1 Collagen 5.4.2 Fibrin 5.4.3 Gelatin 5.4.4 Silk 5.4.5 Alginates 5.4.6 Hyaluronic Acid 5.4.7 Chitin 5.4.8 Cellulose 5.5 Inorganic Glass Based Biomaterials 5.5.1 Silicates 5.5.2 Bioactive Glass 5.5.3 Phosphate 5.6 Radiopaque Biomaterials 5.7 Regenerative Biomaterials 5.8 Hybrid Biomaterial Combinations6 Global Biomaterials Market, by Application 6.1 Cardiovascular 6.1.1 Catheters 6.1.2 Stents 6.1.3 Heart Valves 6.1.4 Guidewires 6.1.5 Sensors 6.1.6 Pacemaker

6.1.7 Implantable Cardiac Defibrillators 6.1.8 Vascular Grafts 6.2 Orthopaedic 6.2.1 Joint Replacement 6.2.1.1 Hip Replacements 6.2.1.2 Knee Replacements 6.2.1.3 Shoulder Replacements 6.2.1.4 Other Replacements 6.2.2 Viscossupplementation 6.2.3 Bioresorbable Tissue Fixation 6.2.3.1 Suture Anchors 6.2.3.2 Interference Screws 6.2.3.3 Meshes 6.2.4 Spine 6.2.4.1 Minimally Invasive Fusion

Surgeries 6.2.4.2 Motion Preservation and

Dynamic Stabilization 6.2.4.2.1 Pedicle Based Rod

Systems 6.2.4.2.2 Interspinous Spacers 6.2.4.2.3 Disc Arthoplasty/

Replacement 6.2.5 Fracture Fixation 6.2.5.1 Bone Plates 6.2.5.2 Screws 6.2.5.3 Pins 6.2.5.4 Rods 6.2.6 Orthobiology 6.2.6.1 Bone Grafts 6.3 Ophthalmology 6.3.1 Contact Lenses 6.3.2 Intraocular Lenses 6.3.3 Functional Replacement of Ocular

Tissues 6.3.4 Synthetic Corneas 6.3.5 Others 6.4 Dental 6.4.1 Dental Bone Grafts and Substitutes 6.4.2 Dental Membranes 6.5 Wound Healing


www.bisresearch.com

TABLE OF CONTENTS


6.5.1 Wound Closure Devices 6.5.2 Sutures 6.5.3 Staples 6.5.4 Surgical Haemostats 6.5.5 Internatal Tissue Sealants 6.5.6 Adhesion Barriers 6.5.7 Hernia Meshes 6.6 Plastic Surgery 6.6.1 Soft-Tissue Fillers 6.6.2 Craniofacial Surgery 6.7 Neurological/Central Nervous System 6.7.1 Shunting Systems 6.7.2 Cortical Neural Prosthetics (CNP) 6.7.3 Hydrogel Scaffolds for CNS Report 6.7.4 Neural Stem Cell Encapsulation 6.8 Tissue Engineering 6.8.1 Scaffolds for Regenerative Medicine 6.8.2 Nanomaterial for Biosensing 6.8.3 Tailoring of Inorganic Nanoparticles 6.9 Others 6.9.1 Drug Delivery Systems 6.9.2 Gastrointestinal Applications 6.9.3 Bariatric Surgery 6.9.4 Urinary Applications7 Global Biomaterials Market, by Region 7.1 North America 7.1.1 Biomaterials Market, by Type 7.1.2 Biomaterials Market, by Application 7.1.3 Biomaterials Market, by Country 7.1.3.1 The U.S. 7.1.3.1.1 Biomaterials-Based

Research in the U.S 7.1.3.1.2 Growing Demand for

Plastic Surgeries in the U.S.

7.1.3.1.3 Conferences and Symposiums on Biomaterials in the U.S.

7.1.3.1.4 Increase in Cancer Incidence

7.1.3.1.5 Growing Prevalence of

Cardiovascular Diseases 7.1.3.1.6 Regulations in the U.S. 7.1.3.2 Canada 7.1.3.2.1 Growth in the Aging

Population 7.1.3.2.2 Growing Development

Activities for Biomaterials in Canada

7.1.3.3 Mexico 7.1.3.3.1 Growing R&D activity for

Biomaterials in Mexico 7.1.3.3.2 Emergence of Dental

Growth7.2 Europe 7.2.1 Biomaterials Market, by Type 7.2.2 Biomaterials Market, by Application 7.2.3 Biomaterials Market, by Country 7.2.3.1 Germany 7.2.3.2 The U.K. 7.2.3.3 France 7.2.3.4 Spain 7.2.3.5 Italy 7.2.3.6 Russia 7.2.3.7 Rest of Europe(RoE) 7.3 Asia Pacific 7.3.1 Biomaterials Market, by Type 7.3.2 Biomaterials Market, by Application 7.3.3 Biomaterials Market, by Country 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 South Korea 7.3.3.5 Rest of Asia Pacific 7.4 Middle East & Africa 7.4.1 Biomaterials Market, by Type 7.5 South America 7.5.1 Biomaterials Market, by Type8 Company Profiles 8.1 BASF SE 8.1.1 Company Overview 8.1.2 Financials

www.bisresearch.com

TABLE OF CONTENTS


8.1.2.1 Financial Summary 8.1.3 BASF SE: SWOT Analysis 8.2 Bioactive Bone Substitutes Ltd. 8.2.1 Company Overview 8.2.2 About the Company 8.3 Berkeley Advanced Biomaterials Inc. 8.3.1 Company Overview 8.3.2 Product Portfolio 8.3.3 About the Company 8.4 Bioretec Ltd. 8.4.1 Company Overview 8.4.2 About the Company 8.5 CAM Bioceramics B.V. 8.5.1 Company Overview 8.5.2 About the Company 8.6 Carpenter Technology Corporation 8.6.1 Company Overview 8.6.2 Product Portfolio 8.6.3 Overall Financials 8.6.3.1 Financial Summary 8.6.4 SWOT Analysis 8.7 Celanese Corporation 8.7.1 Company Overview 8.7.2 Product Portfolio 8.7.3 Financials 8.7.3.1 Financial Summary 8.7.4 SWOT Analysis 8.8 Collagen Solutions 8.8.1 Company Overview 8.8.2 Product Portfolio 8.8.3 Overall Financials 8.8.3.1 Financial Summary 8.8.4 SWOT Analysis 8.9 Corbion N.V. 8.9.1 Company Overview 8.9.2 Overall Financials: 8.9.2.1 Financial Summary 8.9.3 SWOT Analysis 8.10 Covestro AG 8.10.1 Company Overview

8.10.2 Product Portfolio 8.10.3 Overall Financials: 8.10.3.1 Financial Summary 8.10.4 SWOT Analysis 8.11 Koninklijke DSM N.V. 8.11.1 Company Overview 8.11.2 Product Portfolio 8.11.3 Overall Financials: 8.11.3.1 Financial Summary 8.11.4 SWOT Analysis 8.12 Evonik Industries 8.12.1 Company Overview 8.12.2 Product Portfolio 8.12.3 Overall Financials: 8.12.3.1 Financial Summary 8.12.4 SWOT Analysis 8.13 Invibio Biomaterial Solutions 8.13.1 Company Overview 8.13.2 About the Company 8.14 Regentis Biomaterials 8.14.1 Company Overview 8.14.2 About the Company 8.15 Zimmer Biomet Holdings Inc. 8.15.1 Company Overview 8.15.2 Product Portfolio 8.15.3 Overall Financials: 8.15.3.1 Financial Summary 8.15.4 SWOT Analysis

www.bisresearch.com

LIST OF TABLE

Table 1 Global Biomaterials Market Snapshot, 2017 and 2021

Table 3.1 Biomaterials Market Competitive Analysis, by Revenue, 2016

Table 3.2 Agreements, Contracts, Collaborations, Joint Ventures & Partnerships

Table 3.3 Key Business Expansion Activities

Table 3.4 Key Product Launches

Table 3.5 Key Mergers & Acquisitions

Table 3.6 Other Developments

Table 5.1 Global Biomaterials Market, by Type, (2016 – 2021)

Table 5.2 Metal based Biomaterials used in the Biomedical Application

Table 5.3 Global Metal Based Biomaterials Market, by Region, (2016 – 2021)

Table 5.4 Synthetic and Natural Polymers Used in Biomedical Applications

Table 5.5 PEEK Based biomaterials

Table 5.6 Global Metal Based Biomaterials Market, by Region, (2016 – 2021)

Table 5.7 Properties of Polymers Needed for Specific Biomaterials Applications

Table 5.8 Overview of Ceramic based Biomaterials Market

Table 5.9 Global Ceramic Based Biomaterials Market, by Region, (2016 – 2021)

Table 5.10 Different Types of Ceramic Needed for Biomaterial Applications

Table 5.11 Collagen Biomaterials Market, by Region, 2016-2021

Table 5.12 Global Inorganic Based Biomaterials Market, by Region, (2016 – 2021)

Table 5.13 Global Radiopaque Biomaterials Market, by Region, (2016 – 2021)

Table 5.14 Global Regenerative Biomaterials Market, by Region, (2016 – 2021)

Table 5.15 Global Hybrid Biomaterials Combinations Market, by Region, (2016 – 2021)

Table 6.1 Application Overview of Biomaterials, by Devices

Table 6.2 Global Biomaterials Market, by Application, (2016 – 2021)

Table 6.3 Biomaterials used in Cardiovascular system

Table 6.4 Cardiovascular Biomaterials Market, by Medical Devices, (2016 – 2021)

Table 6.5 Cardiovascular Biomaterials Market, by Region, (2016 – 2021)

Table 6.6 Factors Leading to the Cardiovascular Diseases in North America

Table 6.7 Biomaterials used in Orthopedic Applications

Table 6.8 Orthopedic Biomaterials Market, by Sub-Application, (2016 – 2021)

Table 6.9 Past vs. Present Materials used in Hip, Shoulder, and Knee Replacements

Table 6.10 Joint Replacement Orthopedic Biomaterials Materials Market, by Type, (2016 – 2021)

Table 6.11 FDA Approved Injectable HA Viscossupplementation Products

Table 6.12 Degradation Time of Biomaterials Used in Bioabsorbable Suture Anchors

Table 6.13 Degradation Time of Biomaterials used in Biresorbable Suture Anchors

Table 6.14 Orthopedic Biomaterials Market, by Region, (2016 – 2021)

Table 6.15 Ophthalmology Biomaterials Market, by Region, (2016 – 2021)

Table 6.16 Dental Biomaterials Market, by Region, (2016-2021)

Table 6.17 Wound Healing Biomaterials Market, by Region (2016-2021)


www.bisresearch.com

LIST OF TABLE


Table 6.18 Surgical Procedures Performed for Plastic Surgery, By Country, 2015

Table 6.19 Non-Surgical Procedures Performed for Plastic Surgery, By Country, 2015

Table 6.20 Plastic Surgery Biomaterials Market, by Region (2016-2021)

Table 6.21 Neurological/Central Nervous System Biomaterials Market, by Region (2016-2021)

Table 6.22 Tissue Engineering Biomaterials Market, by Region (2016-2021)

Table 6.23 Other Applications Biomaterials Market, by Region (2016-2021)

Table 7.1 Global Biomaterials Market, by Region, (2016 – 2021)

Table 7.2 North American Biomaterials Market, by Type, (2016 – 2021)

Table 7.3 North America Biomaterials Market, by Application, (2016 – 2021)

Table 7.4 North American Biomaterials Market by Country, (2016 – 2021)

Table 7.5 The U.S. Biomaterials Market, by Application, (2016–2021)

Table 7.6 Canadian Population on Basis of Age above 65, 1851 to 2041

Table 7.7 Canadian Biomaterials Market, by Application, 2017-2021

Table 7.8 Mexico Biomaterials Market, by Application, 2017-2021

Table 7.9 European Biomaterials Market (2016-2021), by Type

Table 7.10 European Biomaterials Market, by Application, (2016-2021)

Table 7.11 European Biomaterials Market by Country, (2016 – 2021)

Table 7.12 German Biomaterials Market, by Application, (2016–2021)

Table 7.13 The U.K. Biomaterials Market, by Application, (2016–2021)

Table 7.14 France Biomaterials Market, by Application, (2016–2021)

Table 7.15 Spain Biomaterials Market, by Application, (2016–2021)

Table 7.16 Italy Biomaterials Market, by Application, (2016–2021)

Table 7.17 Russian Biomaterials Market, by Application, (2016–2021)

Table 7.18 Rest of Europe Biomaterials Market, by Application, (2016–2021)

Table 7.19 Asia-Pacific Biomaterials Market, by Type, (2016-2021)

Table 7.20 Asia-Pacific Biomaterials Market, by Application, (2016 – 2021)

Table 7.21 Asia-Pacific Biomaterials Market by Country, (2016 – 2021)

Table 7.22 China Biomaterials Market, by Application, (2016–2021)

Table 7.23 Japan Biomaterials Market, by Application, (2016–2021)

Table 7.24 India Biomaterials Market, by Application, (2016–2021)

Table 7.25 South Korean Biomaterials Market, by Application, 2016-2021

Table 7.26 Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021

Table 7.27 Middle East & Africa Biomaterials Market, by Type, (2016 – 2021)

Table 7.28 Middle East & Africa Biomaterials Market, by Application, (2016 – 2021)

Table 7.29 South American Biomaterials Market, by Type, (2016 – 2021)

Table 7.30 South American Biomaterials Market, by Application, (2016 – 2021)

www.bisresearch.com

LIST OF FIGURES

Figure 1 Evolution of BiomaterialsFigure 2 Global Biomaterials Market Snapshot,

2016-2021Figure 3 Global Biomaterials Market Share and

Size, by Type, 2017 and 2021Figure 4 Global Biomaterials Market Share, by

Application: 2017 & 2021Figure 5 Global Biomaterials Market, by Region,

2017 and 2021Figure 6 Global Biomaterials Market, by

Country, 2016 and 2021Figure 1.1 Global Biomaterials Market ScopeFigure 1.2 Report DesignFigure 1.3 Sources of Secondary ResearchFigure 1.4 Data TriangulationFigure 1.5 Top Down & Bottom Up ApproachFigure 2.1 Global Biomaterials Market DynamicsFigure 2.2 Number of Plastic Surgery

Procedures and Percentage Share, by Country, 2014

Figure 2.3 Number of Plastic Surgery Procedures in the U.S., by Type, 2015

Figure 2.4 Global Percentage of Aging Population

Figure 2.5 Global Percentage of Aging Population

Figure 2.6 Cardiovascular Disease Death Rates, By Country, 2014

Figure 2.7 Key Facts about Joint Replacement (2014-2015)

Figure 2.8 Global Medical Implants, by Application

Figure 2.9 Medical Implants in the Human BodyFigure 2.10 Key Trends in the Biomaterials

MarketFigure 3.1 Global Biomaterials Market

Opportunity Matrix, by Region, 2016Figure 3.2 Global Biomaterials Market

Opportunity Matrix, by Country, 2016

Figure 3.3 Global Biomaterials Market Opportunity Matrix, by Country, 2021

Figure 3.4 Country Share Analysis of Global Biomaterials Market, 2016

Figure 3.5 R&D Focus Areas of Axio BioFigure 3.6 R&D Analysis of Key Market PlayersFigure 3.7 Share of Key Market Strategies &

DevelopmentsFigure 3.8 Total Number of Strategies &

DevelopmentsFigure 4.1 Supply Chain Analysis of

Biomaterials MarketFigure 4.2 Biomaterial Science and a Path from

a Need to Manufactured Medical Device

Figure 4.3 Porter’s Five Forces Analysis of Biomaterials Market

Figure 4.4 Future Trends and Developments in the Biomaterials Market

Figure 5.1 Global Biomaterials Market Size, by Type, 2017 and 2021

Figure 5.2 Global Biomaterials Market, by Type, 2016-2021

Figure 5.3 Global Biomaterials Market Share, by Type, 2016-2021

Figure 5.4 Different Types of Biomaterials in Different Applications

Figure 5.5 Global Metal based Biomaterials Market Size, (2016 – 2021)

Figure 5.6 Evolution of Gold based Biomaterials in Medical Applications

Figure 5.7 Application Overview of GoldFigure 5.8 Application Overview of Nitinol Based

BiomaterialsFigure 5.9 Alloy Composition of NitinolFigure 5.10 Global Metal Based Biomaterials

Market, by Region, 2016-2021Figure 5.11 Global Polymer Based Biomaterials

Market, 2017-2021Figure 5.12 Polymer based Biomaterials Market,

by Region, 2016-2021


www.bisresearch.com

LIST OF FIGURES

Figure 5.13 Global Ceramic Based Biomaterials Market, 2017-2021

Figure 5.14 Ceramic Based Biomaterials Market, by Region, 2016-2021

Figure 5.15 Global Natural Biomaterials Market, 2017-2021

Figure 5.16 Collagen Biomaterials Market, by Region, 2016-2021

Figure 5.17 Properties of Inorganic GlassFigure 5.18 Inorganic Glass Based Biomaterials

Market, by Region, 2016-2021Figure 5.19 History of Calcium Phosphate Based

BiomaterialsFigure 5.20 Inorganic Based Biomaterials

Market, by Region, 2016-2021Figure 5.21 Global Radiopaque Biomaterials

Market, 2017-2021Figure 5.22 Radiopaque Biomaterials Market, by

Region, 2016-2021Figure 5.23 Regenerative Biomaterials Market,

by Region, 2016-2021Figure 5.24 Global Hybrid Biomaterial

Combinations Market, 2017-2021Figure 5.25 Hybrid Biomaterial Combinations

Market, by Region, 2016-2021Figure 6.1 Global Biomaterials Market, by

ApplicationFigure 6.2 Global Biomaterials Market, by

Application, 2017 and 2021Figure 6.3 Medical Devices and their Blood

Contact TimeFigure 6.4 Number of Procedures in Joint

Construction, 2016Figure 6.5 Global Ophthalmology Biomaterials

Market, 2017-2021Figure 6.6 Properties of Polymer Based

Biomaterials in OphthalmologyFigure 6.7 Percent Share of Contact Lenses, by

Region, 2014Figure 6.8 Global Dental Biomaterials Market,

(2016-2021)

Figure 6.9 Key Facts and Figures on Dental Implantation in America

Figure 6.10 Global Wound Healing Biomaterials Market, (2016 – 2021)

Figure 6.11 Global Plastic Surgery Biomaterials Market, (2016 – 2021)

Figure 6.12 Global Neurological/Central Nervous System Biomaterials Market, (2016 – 2021)

Figure 6.13 Formation Engineered TissueFigure 6.14 Global Tissue Engineering

Biomaterials Market, (2016 – 2021)Figure 6.15 Properties of Biomaterial ScaffoldsFigure 6.16 Global Other Applications

Biomaterials Market, (2016 – 2021)Figure 7.1 Biomaterials Market Growth Rate, by

RegionFigure 7.2 Biomaterials Market Growth Rate, by

Region, 2017 and 2021Figure 7.3 North American Biomaterials Market

Snapshot, 2016-2021Figure 7.4 Factors Driving the Biomaterials

Market in North American Biomaterials, 2017 and 2021

Figure 7.5 North American Distribution of Orthopedic Surgery Procedures, 2015

Figure 7.6 Surgical Procedures in North America, 2015 and 2016

Figure 7.7 Non-Surgical Procedures in North America, 2015 and 2016

Figure 7.8 The U.S. Biomaterials Market, by Application, 2017-2021

Figure 7.9 Increase in Plastic Surgeries in the U.S. from 2000 to 2015

Figure 7.10 Cancer Cases and Death Estimation in the U.S., 2017

Figure 7.11 Facts and Risks Associated with Cardiovascular Diseases in the U.S.

Figure 7.12 Canadian Biomaterials Market, by Application, 2017-2021


www.bisresearch.com

LIST OF FIGURES


Figure 7.13 Facts and Risks associated with Cardiovascular Diseases in the Canada

Figure 7.14 Mexico Biomaterials Market, by Application, 2017-2021

Figure 7.15 Global European Biomaterials Market, 2017-2021

Figure 7.16 Factors Driving the Biomaterials Market in European Biomaterials, 2017 and 2021

Figure 7.17 Percent Share of different Kind of Diseases in Europe, by Male and Female, 2016

Figure 7.18 German Biomaterials Market, by Application, 2017-2021

Figure 7.19 The U.K. Biomaterials Market, by Application, 2017-2021

Figure 7.20 Common Plastic Surgery Procedure in the U.K.

Figure 7.21 France Biomaterials Market, by Application, 2017-2021

Figure 7.22 Spain Biomaterials Market, by Application, 2017-2021

Figure 7.23 Italy Biomaterials Market, by Application, 2017-2021

Figure 7.24 Russia Biomaterials Market, by Application, 2017-2021

Figure 7.25 Rest of Europe Biomaterials Market, by Application, 2017-2021

Figure 7.26 Asia-Pacific Biomaterials Market Snapshot, 2016-2021

Figure 7.27 Factors Driving the Biomaterials Market in Asia-Pacific, 2017 and 2021

Figure 7.28 China Biomaterials Market, by Application, 2017-2021

Figure 7.29 Japan Biomaterials Market, by Application, 2017-2021

Figure 7.30 India Biomaterials Market, by Application, 2017-2021

Figure 7.31 Percentage of Heart Attack among

Indians for Different Age GroupsFigure 7.32 South Korean Biomaterials Market,

by Application, 2017-2021Figure 7.33 Indonesian Medical Device

Regulation SystemFigure 7.34 Rest of Asia Pacific Biomaterials

Market, by Application, 2017-2021Figure 7.35 Middle East & Africa Biomaterials

Market, 2017-2021Figure 7.36 South American Biomaterials

Market, by Type, 2017-2021Figure 8.1 BASF SE: Overall Financials, 2014-

2016Figure 8.2 BASF SE: Geographic Revenue Mix,

2014-2016Figure 8.3 BASF SE: Business Segment

Revenue Mix, 2014-2016Figure 8.4 Carpenter Technology Corporation:

Overall Financials, 2014-2016Figure 8.5 Carpenter Technology Corporation:

Geographic Revenue Mix, 2014-2016Figure 8.6 Carpenter Technology Corporation:

Business Segment Revenue Mix, 2014-2016

Figure 8.7 Celanese Corporation: Overall Financials, 2014-2016

Figure 8.8 Celanese Corporation: Geographic Revenue Mix, 2014-2016

Figure 8.9 Celanese Corporation: Business Segment Revenue Mix, 2014-2016

Figure 8.10 Collagen Solutions: Overall Financials, 2014-2016

Figure 8.11 Collagen Solutions: Geographic Revenue Mix, 2014-2016

Figure 8.12 Corbion N.V.: Overall Financials, 2014-2016

Figure 8.13 Corbion N.V.: Geographic Revenue Mix, 2014-2016

Figure 8.14 Corbion N.V.: Business Segment Revenue Mix, 2014-2016

Figure 8.15 Corbion N.V.: Biochemical Sub-

www.bisresearch.com

LIST OF FIGURES


Segment Revenue Mix, 2014-2016Figure 8.16 Covestro AG: Overall Financials,

2014-2016Figure 8.17 Covestro AG: Geographic Revenue

Mix, 2014-2016Figure 8.18 Covestro AG: Business Segment

Revenue Mix, 2014-2016Figure 8.19 Koninklijke DSM N.V.: Overall

Financials, 2014-2016Figure 8.20 Koninklijke DSM N.V.: Geographic

Revenue Mix, 2014-2016Figure 8.21 Koninklijke DSM N.V.: Business

Segment Revenue Mix, 2013-2015

Figure 8.22 Evonik Industries: Overall Financials, 2014-2016

Figure 8.23 Evonik Industries: Geographic Revenue Mix, 2014-2016

Figure 8.24 Evonik Industries: Business Segment Revenue Mix, 2014-2016

Figure 8.25 Zimmer Biomet Holdings Inc.: Overall Financials, 2014-2016

Figure 8.26 Zimmer Biomet Holdings Inc.: Geographic Revenue Mix, 2014-2016

Figure 8.27 Zimmer Biomet Holdings Inc.: Business Segment Revenue Mix, 2014-2016

BIS Research provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer’s internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings.

Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies.

For more details regarding permission, please contact us:Email: [email protected]: +1 650 228 0182

DISCLAIMER

www.bisresearch.com


global biomaterials market - analysis and forecast (2017-2021)

Data & Analytics